Literature DB >> 8463171

A novel antimicrobial central venous catheter impregnated with benzalkonium chloride.

S E Tebbs1, T S Elliott.   

Abstract

Catheter-related sepsis is a common complication associated with the use of central venous catheters (CVC). In an attempt to overcome this problem benzalkonium chloride was incorporated into a CVC polymer. The effect of the presence of benzalkonium chloride on microbial colonization of the CVC was then assessed in vitro. MICs and MBCs of benzalkonium chloride for a range of organisms were performed and good activity against Gram-positive organisms was confirmed. In order to assess the antimicrobial activity of the benzalkonium-chloride-impregnated catheter, 2 cm lengths were placed on to nutrient agar plates inoculated with various micro-organisms. Zones of inhibition against five strains of Staphylococcus epidermidis and two strains of Staphylococcus aureus were demonstrated. Smaller zones of inhibition was also produced with Gram-negative species and Candida albicans. The zone sizes correlated with the MICs. Bacterial adherence to the benzalkonium-chloride-impregnated catheters was determined in both static and dynamic models and was significantly reduced compared with control catheters, containing no antimicrobial agent (P < 0.01). Inhibition of microbial adherence to benzalkonium-chloride-impregnated catheters placed in 25% human blood in phosphate-buffered saline (PBS), for up to seven days or PBS alone for 14 days was detected. The findings indicate that benzalkonium-chloride-impregnated catheters exhibit reduced microbial colonization by a range of organisms in vitro. The incorporation of benzalkonium chloride into a CVC may thus offer an effective method for the prevention of catheter related sepsis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463171     DOI: 10.1093/jac/31.2.261

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

Review 1.  Prevention of infections caused by central venous catheters--established and novel measures.

Authors:  A Bach
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Microbicidal activity of a new silver-containing polymer, SPI-ARGENT II.

Authors:  G Kampf; B Dietze; C Grosse-Siestrup; C Wendt; H Martiny
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

3.  Use of pulsed field gel electrophoresis to determine the source of microbial contamination of central venous catheters.

Authors:  M A Livesley; S E Tebbs; H A Moss; M H Faroqui; P A Lambert; T S Elliott
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

4.  Novel approach to investigate a source of microbial contamination of central venous catheters.

Authors:  T S Elliott; H A Moss; S E Tebbs; I C Wilson; R S Bonser; T R Graham; L P Burke; M H Faroqui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

5.  The antibacterial effect of topical anesthetic proparacaine on conjunctival flora.

Authors:  H Oguz; E Oguz; S Karadede; G Aslan
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

6.  Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces.

Authors:  I Francolini; P Norris; A Piozzi; G Donelli; P Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.

Authors:  S L Haynie; G A Crum; B A Doele
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Modification of central venous catheter polymers to prevent in vitro microbial colonisation.

Authors:  S E Tebbs; T S Elliott
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

9.  Wild mushroom extracts as inhibitors of bacterial biofilm formation.

Authors:  Maria José Alves; Isabel C F R Ferreira; Inês Lourenço; Eduardo Costa; Anabela Martins; Manuela Pintado
Journal:  Pathogens       Date:  2014-08-06

10.  The Effect of Topical Ocular Anesthetic Proparacaine on Conjunctival and Nasal Mucosal Flora in Dry Eye Disease Patients.

Authors:  Ozlem Onerci Celebi; Ali Riza Cenk Celebi
Journal:  J Clin Med       Date:  2018-04-09       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.